XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Xtant Medical Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.29+0.00 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $40.82M
- P/E (TTM)
- –
- Dividend yield
- –
Xtant Medical Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $99.40M | $106.80M | $115.20M | $117.50M | $117.67M | $117.18M | $115.77M | – | – | – | – | – | 90.8% | -15.5% |
| Orthobiologics [Member] | $68.42M | $70.43M | $72.89M | $72.89M | $72.32M | $69.08M | $66.42M | $63.20M | $62.28M | $60.47M | $58.61M | $56.05M | 62.5% | -5.4% |
| Spinal Implant [Member] | $30.98M | $36.38M | $42.31M | $44.61M | $45.35M | $48.10M | $49.35M | $50.66M | $48.66M | $40.76M | $32.70M | $22.41M | 28.3% | -31.7% |
| License Revenue [Member] | – | – | $18.72M | – | – | – | – | – | – | – | – | – | – | – |
| License [Member] | – | – | $18.72M | – | – | – | – | – | – | – | – | – | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $103.37M | $113.04M | $122.45M | $121.33M | $116.36M | $110.50M | $105.52M | $101.68M | $99.77M | $93.48M | $85.86M | $76.01M | 94.4% | -11.2% |
| Non-US [Member] | $6.16M | $8.87M | $11.48M | $11.75M | $11.41M | – | $11.75M | – | – | – | – | – | 5.6% | -46.0% |
| Rest Of World [Member] | – | – | – | – | $11.41M | $11.80M | $11.75M | $12.18M | $11.17M | $7.75M | $5.44M | $2.46M | – | – |
From the segment and revenue-disaggregation notes of Xtant Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.